申请人:Merck & Co., Inc.
公开号:US04011326A1
公开(公告)日:1977-03-08
Oxazolo[4,5-b]pyridine substituted in the 2-position with a polyhydrobicycloaryl group are topical anti-inflammatory agents. They are prepared by condensing a 2-amino-3-hydroxypyridine with the appropriate carboxylic compound.
2-聚氢化双环芳基氧唑并[4,5-b]吡啶是一种局部抗炎药,其在2位被聚氢化双环芳基基团取代。该药物通过将2-氨基-3-羟基吡啶与适当的羧酸化合物缩合制备而成。